New treatment paradigm for prostate cancer: abarelix initiation therapy for immediate testosterone suppression followed by a luteinizing hormone-releasing hormone agonist.

Autor: Garnick, Marc B.1, Mottet, Nicolas2
Zdroj: BJU International. Aug2012, Vol. 110 Issue 4, p499-504. 6p. 1 Diagram, 5 Charts.
Databáze: Academic Search Ultimate